CLINICAL_TRIALS
trial_result
· 2012-09-06
Clinical Trial Update: Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer [Phase 2]
Summary
A Phase 2 trial evaluated cetuximab in patients with progressive or recurrent endometrial cancer. Results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-09-06